DNA study confirmed Rhacophorus napoensis in four Vietnamese provinces, extending its verified range about 520 kilometres ...
Jaguar Health family company Napo Pharmaceuticals focuses on essential supportive care and management of neglected toxicities in multiple complicated disease states SAN FRANCISCO, CA / ACCESSWIRE / ...
SAN FRANCISCO, CA & MILAN, ITALY / ACCESSWIRE / June 1, 2021 / Napo EU S.p.A. ("Napo EU"), the Italian subsidiary of Napo Pharmacuticals, Inc. ("Napo Pharma"), which is a wholly owned subsidiary of ...
Napo Pharmaceuticals (Napo), a Jaguar Health, Inc. (NASDAQ:JAGX) family company, today announced that it will exhibit at the Annual Association of Nurses in AIDS Care (ANAC) Conference, which takes ...
As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating ...
InvestorsHub on MSN
Jaguar Health targets mid-2027 MVID NDA filing as crofelemer intestinal failure program advances
Jaguar Health subsidiary Napo Pharmaceuticals is continuing its global crofelemer development program for rare intestinal failure diseases while preparing for a planned mid-2027 New Drug Application ...
Bilbao, Spain — The latest adventures of Napo – the animated hero of a European Agency for Safety and Health at Work video series – aim to raise awareness of workplace violence. EU-OSHA points out ...
Equita Group S.p.A., a leading Italian based investment bank, advising Dragon SPAC; Cantor Fitzgerald & Co. advising Jaguar on non-deal related activities Napo EU S.p.A. ("Napo EU"), the Italian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results